MIRUM PHARMACEUTICALS INC's ticker is MIRM and the CUSIP is 604749101. A total of 112 filers reported holding MIRUM PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $510,782 | -4.0% | 16,164 | -21.4% | 0.00% | – |
| Q2 2023 | $531,991 | -56.5% | 20,564 | -59.6% | 0.00% | -100.0% |
| Q1 2023 | $1,223,699 | +101.4% | 50,945 | +63.5% | 0.00% | 0.0% |
| Q4 2022 | $607,523 | +39.7% | 31,155 | +50.6% | 0.00% | – |
| Q3 2022 | $435,000 | +7.9% | 20,685 | -0.1% | 0.00% | – |
| Q2 2022 | $403,000 | -11.6% | 20,697 | 0.0% | 0.00% | – |
| Q1 2022 | $456,000 | – | 20,697 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 6,470,392 | $204,464,387 | 13.58% |
| NEA Management Company, LLC | 2,186,243 | $69,085,279 | 5.34% |
| TANG CAPITAL MANAGEMENT LLC | 1,137,107 | $35,932,581 | 5.07% |
| BOONE CAPITAL MANAGEMENT LLC | 389,791 | $12,317,396 | 3.89% |
| Highlander Partners, L.P. | 122,980 | $3,886,168 | 3.84% |
| BVF INC/IL | 4,370,024 | $138,092,758 | 3.72% |
| Prosight Management, LP | 353,508 | $11,170,853 | 3.54% |
| Novo Holdings A/S | 1,500,000 | $47,400,000 | 3.50% |
| Nicholas Investment Partners, LP | 1,199,366 | $37,899,966 | 2.83% |
| Eventide Asset Management | 3,958,579 | $125,091,097 | 2.25% |